aiSwingX™ analyzes US filings and reports them as news investors can read.

–

ChatGPT: 0 Claude: 0 Google · Gemini: 0 Perplexity: 0 Meta AI: 0 Amazon: 0 Others: 1

Read by AI & crawlers

ChatGPT0

Claude0

Google · Gemini0

Perplexity0

Meta AI0

Amazon0

Others1

Counted by the name each crawler gives. Google · Gemini includes Googlebot, whose index Google also uses for its AI features; other search engines and bots are in Others.

Filing fact · PTGX · 10-Q · 2026-11-06

Revenue

PROTAGONIST THERAPEUTICS, INC. (PTGX) reported Revenue of USD 274,410,000 for the period from 2026-07-01 to 2026-09-30 in its 10-Q (accession 0001104659-26-123620, filed 2026-11-06).

Period	Value	Verify
2026-07-01 ~ 2026-09-30	$274,410,000	EDGAR ↗
2025-09-30 (comparative)	$4,712,000	EDGAR ↗

Our analysis of this filing → EDGAR filing index ↗ PTGX overview →

Provenance

Company PROTAGONIST THERAPEUTICS, INC. · CIK 1377121
Form 10-Q · Accession 0001104659-26-123620 · Filed 2026-11-06
XBRL tag us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · unit USD · duration

Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.

Cite this

PROTAGONIST THERAPEUTICS, INC. (PTGX) reported Revenue of USD 274,410,000 for the period from 2026-07-01 to 2026-09-30 in its 10-Q (accession 0001104659-26-123620, filed 2026-11-06).
— aiSwingX, https://aiswingx.com/n/0001104659-26-123620/RevenueFromContractWithCustomerExcludingAssessedTax

JSON: /api/v1/facts/0001104659-26-123620/RevenueFromContractWithCustomerExcludingAssessedTax